Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells

Ping-Hsiu Wu,1 Yasuhito Onodera,2 Yuki Ichikawa,3,4 Erinn B Rankin,5 Amato J Giaccia,5 Yuko Watanabe,3 Wei Qian,4 Takayuki Hashimoto,1 Hiroki Shirato,1,6,7 Jin-Min Nam1,6,7 1Department of Radiation Medicine, 2Department of Molecular Biology, Graduate School of Medicine, Hokkaido University, Hokkaid...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wu PH, Onodera Y, Ichikawa Y, Rankin EB, Giaccia AJ, Watanabe Y, Qian W, Hashimoto T, Shirato H, Nam JM
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	gold nanoparticles radiotherapy breast cancer invasion integrin fibronectin Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/7fd4df3235b342629994a93a747c4311
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7fd4df3235b342629994a93a747c4311
record_format	dspace
spelling	oai:doaj.org-article:7fd4df3235b342629994a93a747c43112021-12-02T04:52:29ZTargeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells1178-2013https://doaj.org/article/7fd4df3235b342629994a93a747c43112017-07-01T00:00:00Zhttps://www.dovepress.com/targeting-integrins-with-rgd-conjugated-gold-nanoparticles-in-radiothe-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Ping-Hsiu Wu,1 Yasuhito Onodera,2 Yuki Ichikawa,3,4 Erinn B Rankin,5 Amato J Giaccia,5 Yuko Watanabe,3 Wei Qian,4 Takayuki Hashimoto,1 Hiroki Shirato,1,6,7 Jin-Min Nam1,6,7 1Department of Radiation Medicine, 2Department of Molecular Biology, Graduate School of Medicine, Hokkaido University, Hokkaido, 3Innovation Center, Aisin Seiki Co., Ltd., Aichi, Japan; 4IMRA America, Inc., Ann Arbor, MI, 5Department of Radiation Oncology, Division of Radiation and Cancer Biology, Stanford University Medical Center, Stanford, CA, USA; 6Research Center for Cooperative Projects, Graduate School of Medicine, 7Global Station for Quantum Medical Science and Engineering, Global Institution for Collaborative Research and Education, Hokkaido University, Hokkaido, Japan Abstract: Gold nanoparticles (AuNPs) have recently attracted attention as clinical agents for enhancing the effect of radiotherapy in various cancers. Although radiotherapy is a standard treatment for cancers, invasive recurrence and metastasis are significant clinical problems. Several studies have suggested that radiation promotes the invasion of cancer cells by activating molecular mechanisms involving integrin and fibronectin (FN). In this study, polyethylene-glycolylated AuNPs (P-AuNPs) were conjugated with Arg–Gly–Asp (RGD) peptides (RGD/P-AuNPs) to target cancer cells expressing RGD-binding integrins such as α5- and αv-integrins. RGD/P-AuNPs were internalized more efficiently and colocalized with integrins in the late endosomes and lysosomes of MDA-MB-231 cells. A combination of RGD/P-AuNPs and radiation reduced cancer cell viability and increased DNA damage compared to radiation alone in MDA-MB-231 cells. Moreover, the invasive activity of breast cancer cell lines after radiation treatment was significantly inhibited in the presence of RGD/P-AuNPs. Microarray analyses revealed that the expression of FN in irradiated cells was suppressed by combined use of RGD/P-AuNPs. Reduction of FN and downstream signaling may be involved in suppressing radiation-induced invasive activity by RGD/P-AuNPs. Our study suggests that RGD/P-AuNPs can target integrin-overexpressing cancer cells to improve radiation therapy by suppressing invasive activity in addition to sensitization. Thus, these findings provide a possible clinical strategy for using AuNPs to treat invasive breast cancer following radiotherapy. Keywords: gold nanoparticles, radiotherapy, breast cancer, invasion, integrin, fibronectinWu PHOnodera YIchikawa YRankin EBGiaccia AJWatanabe YQian WHashimoto TShirato HNam JMDove Medical Pressarticlegold nanoparticlesradiotherapybreast cancerinvasionintegrinfibronectinMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 5069-5085 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	gold nanoparticles radiotherapy breast cancer invasion integrin fibronectin Medicine (General) R5-920
spellingShingle	gold nanoparticles radiotherapy breast cancer invasion integrin fibronectin Medicine (General) R5-920 Wu PH Onodera Y Ichikawa Y Rankin EB Giaccia AJ Watanabe Y Qian W Hashimoto T Shirato H Nam JM Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells
description	Ping-Hsiu Wu,1 Yasuhito Onodera,2 Yuki Ichikawa,3,4 Erinn B Rankin,5 Amato J Giaccia,5 Yuko Watanabe,3 Wei Qian,4 Takayuki Hashimoto,1 Hiroki Shirato,1,6,7 Jin-Min Nam1,6,7 1Department of Radiation Medicine, 2Department of Molecular Biology, Graduate School of Medicine, Hokkaido University, Hokkaido, 3Innovation Center, Aisin Seiki Co., Ltd., Aichi, Japan; 4IMRA America, Inc., Ann Arbor, MI, 5Department of Radiation Oncology, Division of Radiation and Cancer Biology, Stanford University Medical Center, Stanford, CA, USA; 6Research Center for Cooperative Projects, Graduate School of Medicine, 7Global Station for Quantum Medical Science and Engineering, Global Institution for Collaborative Research and Education, Hokkaido University, Hokkaido, Japan Abstract: Gold nanoparticles (AuNPs) have recently attracted attention as clinical agents for enhancing the effect of radiotherapy in various cancers. Although radiotherapy is a standard treatment for cancers, invasive recurrence and metastasis are significant clinical problems. Several studies have suggested that radiation promotes the invasion of cancer cells by activating molecular mechanisms involving integrin and fibronectin (FN). In this study, polyethylene-glycolylated AuNPs (P-AuNPs) were conjugated with Arg–Gly–Asp (RGD) peptides (RGD/P-AuNPs) to target cancer cells expressing RGD-binding integrins such as α5- and αv-integrins. RGD/P-AuNPs were internalized more efficiently and colocalized with integrins in the late endosomes and lysosomes of MDA-MB-231 cells. A combination of RGD/P-AuNPs and radiation reduced cancer cell viability and increased DNA damage compared to radiation alone in MDA-MB-231 cells. Moreover, the invasive activity of breast cancer cell lines after radiation treatment was significantly inhibited in the presence of RGD/P-AuNPs. Microarray analyses revealed that the expression of FN in irradiated cells was suppressed by combined use of RGD/P-AuNPs. Reduction of FN and downstream signaling may be involved in suppressing radiation-induced invasive activity by RGD/P-AuNPs. Our study suggests that RGD/P-AuNPs can target integrin-overexpressing cancer cells to improve radiation therapy by suppressing invasive activity in addition to sensitization. Thus, these findings provide a possible clinical strategy for using AuNPs to treat invasive breast cancer following radiotherapy. Keywords: gold nanoparticles, radiotherapy, breast cancer, invasion, integrin, fibronectin
format	article
author	Wu PH Onodera Y Ichikawa Y Rankin EB Giaccia AJ Watanabe Y Qian W Hashimoto T Shirato H Nam JM
author_facet	Wu PH Onodera Y Ichikawa Y Rankin EB Giaccia AJ Watanabe Y Qian W Hashimoto T Shirato H Nam JM
author_sort	Wu PH
title	Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells
title_short	Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells
title_full	Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells
title_fullStr	Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells
title_full_unstemmed	Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells
title_sort	targeting integrins with rgd-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/7fd4df3235b342629994a93a747c4311
work_keys_str_mv	AT wuph targetingintegrinswithrgdconjugatedgoldnanoparticlesinradiotherapydecreasestheinvasiveactivityofbreastcancercells AT onoderay targetingintegrinswithrgdconjugatedgoldnanoparticlesinradiotherapydecreasestheinvasiveactivityofbreastcancercells AT ichikaway targetingintegrinswithrgdconjugatedgoldnanoparticlesinradiotherapydecreasestheinvasiveactivityofbreastcancercells AT rankineb targetingintegrinswithrgdconjugatedgoldnanoparticlesinradiotherapydecreasestheinvasiveactivityofbreastcancercells AT giacciaaj targetingintegrinswithrgdconjugatedgoldnanoparticlesinradiotherapydecreasestheinvasiveactivityofbreastcancercells AT watanabey targetingintegrinswithrgdconjugatedgoldnanoparticlesinradiotherapydecreasestheinvasiveactivityofbreastcancercells AT qianw targetingintegrinswithrgdconjugatedgoldnanoparticlesinradiotherapydecreasestheinvasiveactivityofbreastcancercells AT hashimotot targetingintegrinswithrgdconjugatedgoldnanoparticlesinradiotherapydecreasestheinvasiveactivityofbreastcancercells AT shiratoh targetingintegrinswithrgdconjugatedgoldnanoparticlesinradiotherapydecreasestheinvasiveactivityofbreastcancercells AT namjm targetingintegrinswithrgdconjugatedgoldnanoparticlesinradiotherapydecreasestheinvasiveactivityofbreastcancercells
_version_	1718401016149311488

Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells

Ejemplares similares